The Cure Cancer Research Grants 2027 provide up to A$100,000 for one year to early career researchers in Australia. The round supports research into paediatric and adolescent cancers, cancer immunotherapy, or both.
Applicants begin with an expression of interest. Shortlisted applicants submit a full proposal, which is scored on scientific merit (35%), track record and career development (35%), feasibility (20%) and consumer involvement (10%). Reviewers look at how people affected by cancer are involved in shaping and carrying out the research.
Eligibility Criteria
- Applicants must have the legal right to work in Australia and conduct the research there.
- An institution approved by Australia’s National Health and Medical Research Council must administer the grant.
- Applicants must meet the seven-year career eligibility window as of July 1, 2027. Cure Cancer uses the earlier applicable PhD completion or clinical degree date and may allow extensions for eligible career disruptions.
- Projects must address cancers diagnosed at ages 0–17, cancer immunotherapy, or both.
- Lead investigators must have received less than A$300,000 in cumulative competitive research funding as lead investigator. Salary-only fellowships and awards held as co-investigator do not count toward the cap.
- Chief investigators must commit at least 0.5 full-time equivalent to the project and may submit only one expression of interest. The proposal must not duplicate already funded work.
Funding Details
- Maximum award: A$100,000.
- Duration: Up to 12 months.
- Eligible costs: Direct project expenses such as personnel, consumables, scientific services and equipment.
Key Dates
- Expression of interest deadline: December 2, 2026.
- Shortlist notification: January 28, 2027.
- Full application deadline, by invitation: March 31, 2027.
- Funding decisions: May 28, 2027.
- Funding starts: July 1, 2027.
Further Information